Boston Scientific Recognized with Three Major Awards Amid China Strategy Upgrade

ShanghaiJanuary 25, 2024 PR Newswire -- Recently, at the "6th Global Business Leaders Forum" hosted by the Economic Observer,2023The annual "Dingxin Award" winners list is officially announced, Boston Scientific Corporation wins the award2023Annual "In China "Innovative Practice Cases in China."Not long ago, Boston Scientific Corporation was successively awarded by "21Hosted by the "21st Century Economic Report"2023Annual Large Health Industry“Sunlight”Award, and Top Employers Institute (Top Employers Institute) Selection of“China Outstanding Employer”Title: On the Road to Deepening Presence in China, Boston Scientific Corporation Celebrates Triumph.

Ms. Zhang Jun, President of Boston Scientific Greater China, stated:“Receiving the above-mentioned prestigious awards at the turn of the year fully demonstrates the high recognition from all sectors of society for our achievements in talent cultivation, localized strategy, and business innovation over the past year. Based on the continuous advancement and upgrading of our development strategy in China, we will continue to build a sustainably successful organization. By adopting an embedded development model rooted in China and co-creating win-win outcomes with the local ecosystem, we aim to lead the company to achieve new progress in high-quality development while also contributing to the steady and long-term growth of China's healthcare industry.”

Comprehensively Promote Localization Construction

2023Year of Reform and Opening-up45On the new starting point of high-level opening-up, a series of measures to optimize the foreign investment environment have been introduced by the country, continuously strengthening Boston Scientific's confidence in resonating with the Chinese market. Boston Scientific has also clearly proposed to implement a comprehensive localization strategy, deeply integrating into the Chinese market, accelerating the layout along the upstream and downstream of the industry value chain, to benefit Chinese patients in a more localized way.2023Year10In the month, Boston Scientific announced the establishment of its first production and manufacturing base in China in Shanghai, hoping to enhance the accessibility of cutting-edge medical technologies in the Chinese market through a more resilient and agile local supply chain. On this basis, Boston Scientific also fully leverages its role as a bridge for multinational corporations, utilizing its global resource advantages and innovative expertise to boost China's medical device industry from“Following”Turn to“Lead the Way”, achieving upgrading and development in the global value chain division of labor.2023In the year, Boston Scientific not only completed its investment in a majority stake of China's publicly listed company CIRAD, but also reached a strategic cooperation with New Sight Medical in the field of disposable electronic choledochoscopes. In the future, Boston Scientific will work with more local partners to explore collaboration opportunities in R&D, manufacturing, and commercialization, further promoting...“Made in China”Going Global: Integrating Chinese Innovation into the Global Healthcare Ecosystem

By Deepening Presence in China's Medical Industry Value Chain and Strategic Initiatives for a New Business Cycle, Boston Scientific Wins "Dingxin Award"2023Year“In China For China”Innovative Practice CasesThe special honor. The award, hosted by the Economic Observer, aims to find and pay tribute to multinational companies that focus on long-term innovation and are deeply committed to the Chinese market. This year marks the third consecutive year that Boston Scientific has been awarded the "Dingxin Award," demonstrating full recognition of Boston Scientific's continuous acceleration in local construction.

Deepen Talent Cultivation and Capacity Building

Boston Scientific firmly believes that talent is the key element for a company to achieve sustainable development. Over the past year, Boston Scientific has continuously deepened innovative practices in the fields of talent attraction, employee benefits, corporate culture, and talent development, as recognized by the Top Employers Institute.“China Outstanding Employer2024”In the list, Boston Scientific made the list again, consecutively6Year蝉联“China Outstanding Employer”。

To attract a wide range of talents, Boston Scientific has customized a multi-level recruitment approach: campus recruitment.“Starlight Program”For fresh graduatesYoung TalentWe provide a promising and competitive development platform, continuously infusing fresh talent into the industry;“Boston Scientific Research Institute”The live broadcast features industry experts and internal/external guests discussing career choices and professional development, showcasing the broad development opportunities for workplace elites.“GM Coffee Talk”Specially invited future business leaders to gain an in-depth understanding of Boston Scientific, interact closely with the company's management, and assist top talents in connecting with Boston Scientific.“Two-way奔赴”; and newly established for former employees“Boston Scientific Alumni Association”, providing a platform for alumni reunions, welcoming them to unlock hot job positions, encouraging the recommendation of high-quality industry talents, and promoting the return and absorption of diversified talents to the company. Adhering to“People-oriented”The concept,2023In [Year], Boston Scientific upgraded its employee benefits system by launching a flexible benefits plan, providing comprehensive support for the health risk protection and long-term financial planning of employees and their families.2024At the beginning of the year, the company also focused on“Physical Vitality”、“Heart Power”And“Wealth Protection Power”Three Major Themes Launch Comprehensive Health Series Activities, Providing All-Round Health Care for Employees. Over the past year, Boston Scientific's corporate culture has been officially refreshed and upgraded.“Effective Innovation”“Multi-collaboration”“Winning Spirit”“Caring Heart”Four Major Cultural Elements Become New Drivers for Continuous Collaboration Between Employees and the Company. In creating a more inclusive work environment and fostering“Employee Well-being First”While fostering a collaborative team environment, Boston Scientific remains committed to investing in people and empowering employees to continuously push boundaries. Since2022Founded in“Go with the Flow, Envision the Future”The platform has once again leveled up, attracting more than1200Participants engage in a variety of training programs, empowering employees at all levels to fully utilize their potential, create value, and achieve growth.

Steadily Enhance Category Leadership

The foundation for the continuous development of medical innovation enterprises is to constantly provide more suitable medical solutions for a wide range of patients. To meet the diverse diagnostic and treatment needs of patients in China, Boston Scientific continuously introduces breakthrough technologies, products, and procedures, filling the technical gaps in clinical diagnosis and treatment in China, and continuously strengthening its category leadership in the field of minimally invasive intervention. This time, in the "21The 21st Century Economic Report》, in collaboration with authoritative industry experts and scholars, comprehensively evaluated enterprises based on multi-dimensional indicators such as industry position, R&D capabilities, product and service innovation, and selected2023Annual Large Health Industry“Sunshine Award”Case. With2023Innovative Practices in Accelerating Product Access Win Unanimous Recognition for Boston Scientific“Annual Industry Excellence Award”Title.

As the world's first to gather“Ice”、“Fire”、“Electricity”Full-energy Ablation Therapy Medical Device Company, Boston Scientific Corporation Faces Challenges in China1200Patients with Atrial Fibrillation^[1]The disease burden is accelerating the introduction of pulsed electric field ablation in China (PFA) Technology——FARAPULSE PFASystem.2023Year, the product was in the exploration of innovative access“Expressway”Full acceleration: Not only launched in the Boao Lecheng Pilot Zone“Pilot First”And real-world research, also leveraging“Greater Bay Area Medical Device Access Program”Policy, becoming one of the first in the industry to achieve“Equipment+Consumables”Medical devices that have simultaneously received clinical urgent import approval in the Greater Bay Area have begun operations in the Greater Bay Area.“Pilot first”The process. As of now, Boston Scientific has a total of3Products Selected“Green Channel”、6Approval via Boao Lecheng“Pilot First”Entering clinical use,1This product has been approved for marketing with the support of real-world study data, benefiting Chinese patients in advance.

China is one of the most attractive medical technology markets globally, where the unmet needs of a vast patient population, the development opportunities offered by a first-class business environment, and the innovative vitality of local talent all inspire us to continue深耕ing the Chinese market. Looking ahead, Boston Scientific will remain firmly committed to being the most loyal partner to China's healthcare industry, contributing to the sustainable and high-quality development of China's healthcare sector, and assisting in its advancement.“Healthy China”Grand Goals Achieved at an Early Date.

About Boston Scientific

Boston Scientific Corporation is committed to innovation for life. We are dedicated to innovative medical solutions that improve the lives of patients worldwide. For over four decades, Boston Scientific has been at the forefront of the global medical technology industry, providing a wide range of high-performance medical solutions to meet critical treatment needs for a broad patient population while reducing healthcare costs. Boston Scientific's medical devices and related therapies assist physicians in diagnosing and treating complex diseases of the cardiovascular, respiratory, digestive, oncological, neurological, and urological systems.

About Boston Scientific Greater China

Boston Scientific1997Established the China headquarters in Shanghai in the year, with current branches in Beijing, Guangzhou, Chengdu, Hong Kong, and Taipei. The company's core business scope covers interventional cardiology, structural heart disease, cardiac rhythm management, electrophysiology, endoscopic intervention, oncology intervention, peripheral intervention, urology, respiratory intervention, ENT, and neuromodulation. Upholding the tradition of being an innovation leader, Boston Scientific is committed to becoming a medical technology company that meets the needs of doctors and patients, demonstrates innovative vitality, and commands respect by providing high-quality medical products and services for prevention, diagnosis, and treatment. For more detailed information, please visit the company website:www.bostonscientific.cn

^[1]"Chinese Guidelines for the Diagnosis and Treatment of Atrial Fibrillation" 2023 Edition